Bank of America
PETX

Bank of America’s Aratana Therapeutics, Inc. PETX Stock Holding History

Bank of America’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-20,000
Closed -$302K – 7554
2015
Q2 		$302K Hold
20,000
– – ﹤0.01% 5031
2015
Q1 		$320K Buy
+20,000
New +$356K ﹤0.01% 4619

Other funds holding PETX

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Bank of America's PETX Position: Q3 2019 in Review

Bank of America sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 19,959 shares — an estimated $103K sold.

Bank of America first reported a position in PETX in Q4 2013 and held it in 23 quarters. The position peaked at $754K in Q2 2015. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • Bank of America reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Bank of America sold 19,959 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $103K.
  • Bank of America first reported a position in Aratana Therapeutics, Inc. in Q4 2013 and held it in 23 quarters.
  • Bank of America's Aratana Therapeutics, Inc. position peaked at $754K in Q2 2015.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Bank of America's 13F filing for Q3 2019, filed 14 Nov 2019.